Emerging in the field of obesity management, retatrutide is a unique method. Unlike many current medications, retatrutide operates as a twin agonist, simultaneously targeting both glucagon-like peptide-1 (GLP-1) and https://iwanafiy545892.fitnell.com/79485433/this-novel-retatrutide-a-glp-gip-sensor-agonist